International Journal of Cancer Management

Published by: Kowsar

Triple Therapy with Doxorubicin, Imatinib and Tamoxifen in Recurrence Desmoids Tumor Associated with Pregnancy: Case Report and Literature Review

Mozaffar Aznab 1 , *
Author Information
1 Medical Oncologist-Hematologist, Associate Professor of Kermanshah University of Medical Sciences, Iran
Article information
  • Iranian Journal of Cancer Prevention: January 2017, 10 (1); e5476
  • Published Online: January 25, 2017
  • Article Type: Case Report
  • Received: January 24, 2016
  • Revised: March 4, 2016
  • Accepted: January 7, 2017
  • DOI: 10.17795/ijcp-5476

To Cite: Aznab M. Triple Therapy with Doxorubicin, Imatinib and Tamoxifen in Recurrence Desmoids Tumor Associated with Pregnancy: Case Report and Literature Review, Int J Cancer Manag. 2017 ; 10(1):e5476. doi: 10.17795/ijcp-5476.

Abstract
Copyright © 2017, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Footnotes
References
  • 1. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollock RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999; 17(1): 158
  • 2. Goto T, Nemoto T, Ogura K, Hozumi T, Funata N. Successful treatment of desmoid tumor of the chest wall with tranilast: a case report. J Med Case Rep. 2010; 4: 384[DOI][PubMed]
  • 3. Johner A, Tiwari P, Zetler P, Wiseman SM. Abdominal wall desmoid tumors associated with pregnancy: current concepts. Expert Rev Anticancer Ther. 2009; 9(11): 1675-82[DOI][PubMed]
  • 4. Faycal O, Lamia G, Sonia M, Karima M, Mahmoud S, Samir B, et al. Place des therapeutiques medicales dans la prise en charge des tumeurs desmoides de l'enfant. Journal de Pediatrie et de Puericulture. 2005; 18(2): 62-8[DOI]
  • 5. Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer. 2003; 97(4): 1134-5[DOI][PubMed]
  • 6. de Camargo VP, Keohan ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer. 2010; 116(9): 2258-65[DOI][PubMed]
  • 7. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004; 100(3): 612-20[DOI][PubMed]
  • 8. Klein WA, Miller HH, Anderson M, DeCosse JJ. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer. 1987; 60(12): 2863-8[PubMed]
  • 9. Penel N, Le Cesne A, Bui BN, Perol D, Brain EG, Ray-Coquard I, et al. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol. 2011; 22(2): 452-7[DOI][PubMed]
  • 10. Phillips SR, A'Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg. 2004; 91(12): 1624-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments